Rs. 386.63
Not Available

Cystofert Tablet

(10 tablets in strip)
Cystofert Tablet
Product Details
Cystofert Tablet contains Inositol and Folic Acid. It may support female reproductive health and contributes to daily folate intake. The tablet provides a convenient way to include essential nutrients as part of a daily routine and may support overall nutritional needs.

Key Ingredients:
Each serving per uncoated chewable tablet contains: (Approx.)
  • Myo-Inositol 1100 mg
  • Inositol (as D-Chiro-Inositol) 27.6 mg
  • Folic Acid 100 mcg
  • Other Ingredients: Bulking Agent (INS 421), Binder (INS 1201), Acidity Regulator (INS 330), Lubricant [INS 470 (iii)], Gildant (INS 551), Sweetener (INS 951), Preservative (INS 211), and n-pteroyl-l-glutamic acid

Key Benefits:
  • Reproductive Support: May support female reproductive health
  • Folate Source: Contributes to daily folate intake
  • Nutritional Support: Helps maintain general nutritional balance
  • Skin and Hair Support: May help in maintaining healthy skin and hair

Concerns It Can Help With:
Supporting female nutritional needs

Product Form:
Tablet

Net Quantity:
10 N

Directions for Use:
  • One tablet a day or as directed by the healthcare professional
  • Chew the tablet well before you swallow it

Safety Information:
  • Read the label carefully before use
  • Keep out of the reach and sight of children
  • Store in a cool and dry place
  • Not to exceed the stated recommended daily usage
  • Store at a temperature not exceeding 25C
  • Protect from light and moisture
  • This product is not intended to diagnose, treat, cure, or prevent any disease
  • Health supplement is not to be used as a substitute for a varied diet
  • Not for medicinal use
  • Contains artificial sweetener and for calorie conscious
  • Appropriate overages of vitamins added to compensate loss on storage
  • Contains permitted synthetic food colour (INS 110) and added flavours (Nature identical orange and cooler flavouring substances)

Content on this page was last updated on 31 October, 2025, by Dr. Rajeev Sharma (MBA, MBBS)